ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000263004.1	Motesanib	Colon adenocarcinoma	0.019594603	Resistant
ENSG00000263004.1	Motesanib	Lung squamous cell carcinoma	0.048633641	Sensitive